{
    "id": "dbpedia_4254_3",
    "rank": 96,
    "data": {
        "url": "http://rmi.com.ru/en",
        "read_more_link": "",
        "language": "en",
        "title": "RusnanoMedInvest is venture capital company specializing in pharmaceuticals and biotechnology",
        "top_image": "http://rmi.com.ru/images/rusnano/logo_en.png",
        "meta_img": "http://rmi.com.ru/images/rusnano/logo_en.png",
        "images": [
            "http://rmi.com.ru/images/rusnano/logo_en.png",
            "http://rmi.com.ru/files/dynamic_img/19/kolba_i_ruka.jpg",
            "http://rmi.com.ru/files/dynamic_img/25/kolby_i_listya.jpg",
            "http://rmi.com.ru/files/dynamic_img/26/ruki.jpg",
            "http://rmi.com.ru/files/dynamic_img/24/moleculaDNA.jpg",
            "http://rmi.com.ru/files/logo_portfolio/NovaMedica-eng.png",
            "http://rmi.com.ru/files/logo_portfolio/binx.png",
            "http://mc.yandex.ru/watch/18695725"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            "RusnanoMedInvest",
            "RMI",
            "venture",
            "investment",
            "pharmaceutical",
            "biotech",
            "capital",
            "Russia",
            "clinical trials",
            "medical device",
            "health"
        ],
        "tags": null,
        "authors": [],
        "publish_date": null,
        "summary": "",
        "meta_description": "RusnanoMedInvest (RMI) is Russia’s and Eastern Europe’s largest venture capital company specializing in innovative developments in the field of pharmaceuticals and biotechnology",
        "meta_lang": "",
        "meta_favicon": "/images/rusnano/favicon.ico",
        "meta_site_name": "",
        "canonical_link": "http://rmi.com.ru/",
        "text": "RusnanoMedInvest (RMI) is Russia’s and Eastern Europe’s largest venture capital company specializing in innovative developments in the field of pharmaceuticals and biotechnology\n\nRMI was created in March 2012. The investor of RMI is RUSNANO, the nanotechnology investment, research and development arm of the Russian Government.\n\nThe RusnanoMedInvest fund seeks, in addition to securing differentiated and sustainable returns to its investment portfolio, to promote the following social and developmental objectives in Russia. The main objectives of RMI are:\n\nlocalization of innovative life sciences and pharmaceutical technology in Russia;\n\ncreation and accumulation of Russian-originated world-class expertise in the field of venture capital financing in Life Sciences;\n\nstimulating the interest of investors and potential investors in the financing of Russian life sciences ideas, concepts and technologies."
    }
}